Published in J Am Coll Cardiol on February 01, 1996
Right ventricular dyssynchrony in patients with pulmonary hypertension is associated with disease severity and functional class. Cardiovasc Ultrasound (2005) 1.07
Right ventricular plasticity and functional imaging. Pulm Circ (2012) 0.87
Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy. Pulm Circ (2015) 0.87
New approaches to the treatment of pulmonary hypertension: from bench to bedside. Cardiol Rev (2010) 0.80
Lung transplantation for pulmonary hypertension. Pulm Circ (2011) 0.77
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Medical and surgical management for pulmonary arterial hypertension. Ann Thorac Med (2014) 0.77
Surgical treatment of pulmonary hypertension: Lung transplantation. Pulm Circ (2011) 0.75
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet (1984) 2.91
Veno-venous bypass without systemic anticoagulation for transplantation of the human liver. Surg Gynecol Obstet (1985) 2.88
Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci U S A (1999) 2.88
Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. Transplantation (1986) 2.82
Multi-valvular endocarditis. Clin Microbiol Infect (2000) 2.52
Lessons learned in pediatric heart transplantation. Ann Thorac Surg (1989) 2.46
Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med (1996) 2.21
Cardiac transplantation with cyclosporin A and prednisone. Ann Surg (1982) 2.21
Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci U S A (1997) 2.16
Alternative approach to multivessel coronary disease with integrated coronary revascularization. J Thorac Cardiovasc Surg (1999) 2.08
Blood usage in lung transplantation. Transfusion (1998) 2.06
Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg (1995) 1.92
Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis (1985) 1.88
Minimally invasive coronary artery bypass grafting. Ann Thorac Surg (1996) 1.81
Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. Circulation (2000) 1.76
Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation (2001) 1.74
Mitral annular descent velocity by tissue Doppler echocardiography as an index of global left ventricular function. Am J Cardiol (1996) 1.73
Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation (1987) 1.71
Early Function of Heart, Liver, and Kidney Allografts Following Combined Procurement. Transplant Proc (1984) 1.66
Traumatic aortic rupture: diagnosis and management. Ann Thorac Surg (1998) 1.64
Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant (1999) 1.63
Hyperuricemia and gout among heart transplant recipients receiving cyclosporine. Am J Med (1992) 1.58
Effects of aging on left atrial reservoir, conduit, and booster pump function: a multi-institution acoustic quantification study. Heart (2001) 1.58
Long-term survivors of pediatric heart transplantation: a multicenter report of sixty-eight children who have survived longer than five years. J Pediatr (1997) 1.57
Principles of multiple organ procurement from cadaver donors. Ann Surg (1983) 1.56
Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant (1992) 1.54
Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg (1995) 1.54
Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin. Transplantation (1990) 1.52
Large airway inflammation in heart-lung transplant recipients--its significance and prognostic implications. Transplantation (1990) 1.51
Translation of satellite tobacco necrosis virus ribonucleic acid. I. Characterization of in vitro procaryotic and eucaryotic translation products. Biochemistry (1972) 1.50
Gene knockout of the alpha6 subunit of the gamma-aminobutyric acid type A receptor: lack of effect on responses to ethanol, pentobarbital, and general anesthetics. Mol Pharmacol (1997) 1.50
Organ procurement for pulmonary transplantation. Ann Thorac Surg (1989) 1.49
Fluorine-19 nuclear magnetic resonance imaging and spectroscopy of sevoflurane uptake, distribution, and elimination in rat brain. Anesthesiology (1995) 1.48
Regional low-flow perfusion provides cerebral circulatory support during neonatal aortic arch reconstruction. J Thorac Cardiovasc Surg (2000) 1.48
Single- versus double-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg (1998) 1.46
Assessment of left ventricular contractile state by preload-adjusted maximal power using echocardiographic automated border detection. J Am Coll Cardiol (1998) 1.45
Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant (1992) 1.45
Endobronchial management of benign, malignant, and lung transplantation airway stenoses. Ann Thorac Surg (1995) 1.45
Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit. J Heart Lung Transplant (1994) 1.43
Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis (1985) 1.43
Gout in the heart transplant recipient: physiologic puzzle and therapeutic challenge. Am J Med (1989) 1.42
Abciximab and excessive bleeding in patients undergoing emergency cardiac operations. Ann Thorac Surg (1998) 1.41
Proteins of the respiratory tract after heart-lung transplantation. Transplantation (1989) 1.40
A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation. Transplant Proc (1991) 1.40
Predicting ICU length of stay following single lung transplantation. Chest (1996) 1.40
Prediction of mortality in patients awaiting cardiac transplantation: increased risk of sudden death in ischemic compared to idiopathic dilated cardiomyopathy. Isr J Med Sci (1996) 1.40
Clinical cardiopulmonary bypass without systemic anticoagulation. Ann Thorac Surg (1993) 1.39
Bronchiolar carcinoma: a report of six cases. Can Med Assoc J (1966) 1.38
Clinical experience with the Medtronic-Hall valve prosthesis. Ann Thorac Surg (1990) 1.38
Cytomegaloviral infections in the guinea pig: experimental models for human disease. Rev Infect Dis (1983) 1.38
Coronary artery fistula in the heart transplant patient. A potential complication of endomyocardial biopsy. Circulation (1989) 1.37
Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J Infect Dis (1991) 1.35
Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant (1996) 1.29
Evaluation of R-Mix FreshCells in shell vials for detection of respiratory viruses. J Clin Microbiol (2000) 1.28
Survival of HIV-1 in syringes. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.27
An implantable centrifugal blood pump for long term circulatory support. ASAIO J (1998) 1.24
Heart-lung transplantation: lessons learned and future hopes. Ann Thorac Surg (1987) 1.23
Cerebral responses to noxious thermal stimulation in chronic low back pain patients and normal controls. Neuroimage (2002) 1.23
Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg (1996) 1.22
The placenta as a site of cytomegalovirus infection in guinea pigs. J Virol (1985) 1.20
Does transplantation produce quality of life benefits? A quantitative analysis of the literature. Transplantation (1997) 1.19
An implantable centrifugal blood pump with a recirculating purge system (Cool-Seal system). Artif Organs (1998) 1.19
Clinical trial of FK 506 immunosuppression in adult cardiac transplantation. Ann Thorac Surg (1992) 1.18
NMR study of volatile anesthetic binding to nicotinic acetylcholine receptors. Biophys J (2000) 1.18
Prevalence and risk of depression and anxiety-related disorders during the first three years after heart transplantation. Psychosomatics (2001) 1.17
Pharmacologic and behavioral responses of inbred C57BL/6J and strain 129/SvJ mouse lines. Pharmacol Biochem Behav (1999) 1.17
Influence of the donor lung on development of early infections in lung transplant recipients. J Heart Transplant (1990) 1.17
Efficacy of S26308 against guinea pig cytomegalovirus infection. Antimicrob Agents Chemother (1988) 1.17
Characterization of a deficiency of N6-(delta 2-isopentenyl)-2-methylthioadenosine in the Escherichia coli mutant trpX by use of antibodies to N6-(delta 2-isopentenyl)adenosine. J Biol Chem (1979) 1.16
Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients. Am J Kidney Dis (1987) 1.15
Cytomegalovirus infection in guinea pigs. IV. Maternal infection at different stages of gestation. J Infect Dis (1980) 1.15
Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation (1991) 1.13
Pulmonary valvulotomy alone for pulmonary stenosis: results in children with and without muscular infundibular hypertrophy. J Thorac Cardiovasc Surg (1982) 1.13
Cytomegalovirus-induced mononucleosis in guinea pigs. Infect Immun (1981) 1.12
Risk stratification using the Society of Thoracic Surgeons Program. Ann Thorac Surg (1994) 1.12
Host defense response to cytomegalovirus in the central nervous system. Predominance of the monocyte. Am J Pathol (1989) 1.12
Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506. Transplantation (1991) 1.10
Extracorporeal membrane oxygenation in children. New trends. J Thorac Cardiovasc Surg (1988) 1.10
The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol (1989) 1.08
Targeted blood levels of cyclosporin for cardiac transplantation. J Thorac Cardiovasc Surg (1984) 1.07
Mortally ill patients and excellent survival following cardiac transplantation. Ann Thorac Surg (1986) 1.07
Quality-of-life advantages of FK 506 vs conventional immunosuppressive drug therapy in cardiac transplantation. Transplant Proc (1991) 1.07
A gait-powered autologous battery charging system for artificial organs. ASAIO J (1996) 1.06
Cardiopulmonary bypass is associated with early allograft dysfunction but not death after double-lung transplantation. J Thorac Cardiovasc Surg (1998) 1.06
Implantable electrical left ventricular assist system: bridge to transplantation and the future. Ann Thorac Surg (1989) 1.06
Letter to an ethicist: resuscitative interventions. CMAJ (1996) 1.05
Heart transplantation in patients with malignant disease. J Heart Transplant (1991) 1.05
Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey. Circulation (1991) 1.04
Potential influence of intraluminal thrombus on abdominal aortic aneurysm as assessed by a new non-invasive method. Cardiovasc Surg (1996) 1.04
Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team. J Infect Dis (1998) 1.04
Advantages of venous bypass during orthotopic transplantation of the liver. Semin Liver Dis (1985) 1.02
Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant (1992) 1.02
Powerful but limited immunosuppression for cardiac transplantation with cyclosporins and low-dose steroid. J Thorac Cardiovasc Surg (1984) 1.02
Experience with univentricular support in mortally ill cardiac transplant candidates. Ann Thorac Surg (1990) 1.02
19F nuclear magnetic resonance investigation of stereoselective binding of isoflurane to bovine serum albumin. Biophys J (1996) 1.01
Prevalence and predictors of depression and anxiety-related disorders during the year after heart transplantation. Gen Hosp Psychiatry (1996) 1.01